SEC Form 4 · accession 0001209191-15-060247
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Mahoney
Director
Period of report
Jul 8, 2015
Accepted (ET)
Jul 9, 2015 · 1:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jul 8, 2015 | S | 33,828 | $5.7369 | D | 1,169,320 | I | David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold. The sale prcies ranged from $5.60 to $5.98 per share.